Clinical trial
A Multi-Center, Open-Label, Surgical Surveillance Trial To Evaluate The Safety And Efficacy Of A Shortened Infusion Time of Intravenous Ibuprofen
NCT01334957 is registered in ClinicalTrials.gov with Cumberland Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-Center, Open-Label, Surgical Surveillance Trial To Evaluate The Safety And Efficacy Of A Shortened Infusion Time of Intravenous Ibuprofen
- Lead sponsor
- Cumberland Pharmaceuticals
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- January 31, 2013
- Enrollment
- 300 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.